Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More
Xconomy
JULY 22, 2016
It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment. —Bruce Bigelow profiled Dauntless Pharmaceuticals , a stealthy biotech company creator in San Diego forming single-drug startups.
Let's personalize your content